1. Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis. (3rd October 2022) Authors: Mendieta Badimon, G; Mehta, S; Baber, U; Collier, T; Dangas, G; Sharma, S K; Cohen, D J; Angiolillo, D; Briguori, C; Escaned, J; Gabriel Steg, P; Huber, K; Michael Gibson, C; Pocock, S; Mehran, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P4403Inhibitory mechanisms of very low dose rivaroxaban in non-ST-elevation myocardial infarction. (28th August 2018) Authors: Borst, O; Muenzer, P; Alnaggar, N; Geue, S; Tegtmeyer, R; Rath, D; Heemskerk, J W M; Jennings, L K; Angiolillo, D; Spronk, H; Ten Cate, H; Gawaz, M; Geisler, T Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗